A Randomized Phase II Trial of Preoperative Chemoradiation (Preop CRT) Followed by CapOx (Capecitabine Plus Oxaliplatin) Versus Preop CRT Alone for Locally Advanced Rectal Cancer (LARC)
Latest Information Update: 05 Nov 2021
At a glance
- Drugs Capecitabine (Primary) ; Oxaliplatin (Primary) ; Fluorouracil
- Indications Adenocarcinoma; Rectal cancer
- Focus Therapeutic Use
- Acronyms PREPARE
- 24 Jun 2017 New trial record
- 06 Jun 2017 Primary endpoint (downstaging rate) has not been met, according to the results presented at the 53rd Annual Meeting of the American Society of Clinical Oncology
- 06 Jun 2017 Results presented at the 53rd Annual Meeting of the American Society of Clinical Oncology